30

Henan Newland Pharmaceutical Co LtdSHE 301277 Stock Report

Last reporting period 30 Sep, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

0.756

Micro

Exchange

XSHE - Shenzhen Stock Exchange

301277.SZ Stock Analysis

30

Uncovered

Henan Newland Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.756

Dividend yield

1.74 %

Shares outstanding

133.36 B

Henan Newland Pharmaceutical Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The Company's main business is the research and development, production and sales of pharmaceutical intermediates. The Company's main products are L-p-hydroxyphenylglycine series products and p-toluenesulfonic acid, including D-acid, methyl ester and hydroxydeng salt. The Company also produces pharmaceutical resolution agents. The Company mainly operates its businesses in the domestic and overseas markets.

View Section: Eyestock Rating